Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer. - Hamilton E; Pluard T; Wang JS; Morikawa A; Johnston S; Dees EC; Vaklavas C; Armstrong A; Munster P; Unni N; Wright GS; Kayali F; et al. (Breast cancer research : BCR, 2025)